AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT VALINE, LEUCINE, ISOLEUCINE AND SUPPLEMENTED WITH ARACHIDONIC ACID AND DOCOSAHEXAENOIC ACID
Information current as at: 1 June 2026
PBAC meeting date: July 2026
Submission Details
- Brand name:
-
- MSUD explore5®
- Form and strength:
-
- Sachets containing oral powder 12.5 g, 30 (MSUD Explore5)
- Submission sponsor:
- VITAFLO AUSTRALIA PTY LIMITED
- Condition/indication:
(therapeutic use) -
- Short-chain Enoyl co-A Hydratase (ECHS1) deficiency and 3-Hydroxyisobutyryl co-A Hydrolase (HIBCH) deficiency
- Listing requested:
- To request listing of MSUD explore5 for the dietary management of patients aged 6 months to 5 years with a proven diagnosis of either ECHS1 or HIBCH deficiency.
- Funding program:
- PBS General Schedule
- Request authority level:
- Restricted Benefit
- PBAC Submission type:
- Change to existing listing (–)
- Comment:
- --
- Other PBAC consideration:
- --
Progress Details
-
Submission received for: - July 2026 PBAC meeting
-
Opportunity for consumer comment: - Open 25/03/2026 and close 20/05/2026 (see PBS Website)
-
3PBAC meeting:
- Has not yet occurred
-
4PBAC outcome published:
- Pending PBAC outcome (see PBAC Outcomes)
-
5Lodgement of required documentation:
-
6Agreement to listing arrangements:
- Has not yet commenced
-
7Government processes:
- Has not yet commenced
-
8Medicine listed on the PBS:
- Has not yet occurred
PBAC Outcome
Case ID
1207
Page last updated
31 May 2026
v.9.19